Sling Therapeutics, Inc., a US-based biopharmaceutical company, announced on Monday that it has named Faheem Hasnain as its new chairman of the company's board of directors.
Hasnain has served as the founder, chief executive officer, and chairman of Gossamer Bio. He also holds the position of the lead independent director for Kura Oncology and is chairman of the board of directors for Aspen Neuroscience, Mirati Therapeutics and SENTÉ. He is the former president and chief executive officer of Receptos, Facet Biotech and PDL BioPharma.
Hasnain has a BHK and a BEd from the University of Windsor.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer